Amanta Healthcare IPO Details
| IPO Open Date: | September 1, 2025 |
| IPO Close Date: | September 3, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹120 to ₹126 Per Share |
| Issue Size: | Approx ₹126 Crores |
| Fresh Issue: | Approx ₹126 Crores |
| Lot Size: | 119 Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Amanta Healthcare IPO Market Lot
The Amanta Healthcare IPO minimum market lot is 119 shares with ₹14,994 application amount. The retail investors can apply up-to 13 lots with 1,547 shares of ₹1,94,922 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 119 | ₹14,994 |
| Retail Maximum | 13 | 1,547 | ₹1,94,922 |
| S-HNI Minimum | 14 | 1,666 | ₹2,09,916 |
| B-HNI Minimum | 67 | 7,973 | ₹10,04,598 |
Amanta Healthcare IPO Dates
The Amanta Healthcare IPO date is September 1, 2025 and the close date is September 3, 2025. The Amanta Healthcare IPO allotment will be finalized on September 4, 2025 and the IPO listing on September 9, 2025.
| IPO Open Date: | September 1, 2025 |
| IPO Close Date: | September 3, 2025 |
| Basis of Allotment: | September 4, 2025 |
| Refunds: | September 5, 2025 |
| Credit to Demat Account: | September 5, 2025 |
| IPO Listing Date: | September 9, 2025 |
Promoters of Amanta Healthcare
The promoters of the company are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Limited.
Business Overview
Amanta Healthcare Limited, founded in December 1994, is one of the leading pharmaceutical companies that is involved in the development, manufacturing, and marketing of a wide range of sterile liquid products, mainly parenterals. These are packed in plastic containers using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. IV fluids, diluents, eye drops, and respiratory care solutions are some of the fluid therapy products that the company makes.
Amanta Healthcare also produces irrigation solutions, first-aid items, and eye lubricants under its medical devices segment. The company markets its products through three business divisions: National Sales, International Sales, and Product Partnerships with various Indian and foreign pharmaceutical companies. Under its own brand, the company makes over 45 generic products and sells them in India, through 320 distributors and stockists. The company employs a total of 1,718 employees as of March 31, 2025.
Amanta Healthcare Financial Report
The company reported revenue of ₹276 crores in 2025 against ₹282 crores in 2024. The company reported profit of ₹10.50 crores in 2025 against profit of ₹3.63 crores in 2024.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹263 | ₹206 | ₹2.11 | ₹374 |
| 2024 | ₹282 | ₹223 | ₹3.63 | ₹352 |
| 2025 | ₹276 | ₹215 | ₹10.50 | ₹382 |
Amanta Healthcare IPO Valuation – FY2025
Check Amanta Healthcare IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 12.42% |
| ROCE: | 13.72% |
| EBITDA Margin: | 22.11% |
| PAT Margin: | 3.86% |
| Debt to equity ratio: | 2.02 |
| Earning Per Share (EPS): | ₹3.71 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 10.89% |
| Net Asset Value (NAV): | ₹33.43 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Denis Chem Lab Limited | 5.82 | 15.92 | 9.49% | 61.33 | 176 Cr. |
Objects of the Issue
- Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
- General Corporate Purposes
Amanta Healthcare IPO Review
- IPO Watch: May Apply
- Invest4Edu Private Limited: Apply
- Scoop Investment: May Apply
- Exencial Research Partners: May Apply
- Minerva Capital Research Solutions: May Apply
- Capital Market: Avoid
Amanta Healthcare IPO Registrar
MUFG Intime India Pvt Ltd.
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://in.mpms.mufg.com/
IPO Lead Managers aka Merchant Bankers
- Beeline Capital Advisors Pvt Ltd.
Company Address
Amanta Healthcare Ltd.
8th Floor, Shaligram Corporates
C.J. Marg, Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: [email protected]
Website: https://www.amanta.co.in/
Amanta Healthcare IPO FAQs
What is Amanta Healthcare IPO?
When Amanta Healthcare IPO will open for subscription?
What is Amanta Healthcare IPO Investors Portion?
How to Apply the Amanta Healthcare IPO?
What is Amanta Healthcare IPO Issue Size?
What is Amanta Healthcare IPO Price Band?
What is Amanta Healthcare IPO Lot Size?
What is the Amanta Healthcare IPO Allotment Date?
What is the Amanta Healthcare IPO Listing Date?
Note: The Amanta Healthcare IPO price band and date are officially announced. The (Amanta Healthcare IPO grey market premium) will be added to the IPO GMP page as it will start).
One Response
The IPO valuations seems bit on a high side. Lets see how the grey market will work on it.